Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene

被引:64
作者
Ben-Chetrit, E
Backenroth, R
机构
[1] Hadassah Univ Hosp, Dept Med, FMF Clin, Rheumatol Unit, IL-91120 Jerusalem, Israel
[2] Hadassah Univ Hosp, Dept Hypertens & Nephrol, IL-91120 Jerusalem, Israel
关键词
D O I
10.1136/ard.60.2.146
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background-Familial Mediterranean fever (FMF) is an autosomal recessive disease characterised by recurrent attacks of fever and serositis. Amyloidosis is the most significant complication of FMF, leading to end stage renal disease (ESRD). Recently the gene (MEFV) causing this disease was cloned and more than 18 mutations have been identified. The hypothesis that the development of amyloidosis is associated with one of these mutations was tested. Methods-23 patients with FMF and ESRD were analysed for their MEFV mutations and correlated with their corresponding rectal and renal biopsies. As case controls 23 patients with FMF free of renal disease, but with similar origin, sex, age, and age at onset of FMF, were chosen. Results-Ah the patients with ESPD induced by amyloidosis were homozygous for the M694V or M694I mutations. This finding was significantly different from that seen in the control group. Conclusions-Amyloidosis is highly associated with the 694 substitution in the MEFV gene causing FMF. It seems that genetic predisposition plays a part in the development of this complication of FMF.
引用
收藏
页码:146 / 149
页数:4
相关论文
共 16 条
[1]
Aksentijevich I, 1997, CELL, V90, P797
[2]
Colchicine: 1998 update [J].
Ben-Chetrit, E ;
Levy, M .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1998, 28 (01) :48-59
[3]
Familial Mediterranean fever [J].
Ben-Chetrit, E ;
Levy, M .
LANCET, 1998, 351 (9103) :659-664
[4]
Bernot A, 1997, NAT GENET, V17, P25
[5]
MEFV-gene analysis in Armenian patients with familial Mediterranean fever:: Diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype -: Genetic and therapeutic implications [J].
Cazeneuve, C ;
Sarkisian, T ;
Pêcheux, C ;
Dervichian, M ;
Nédelec, B ;
Reinert, P ;
Ayvazyan, A ;
Kouyoumdjian, JC ;
Ajrapetyan, H ;
Delpech, M ;
Goossens, M ;
Dodé, C ;
Grateau, G ;
Amselem, S .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (01) :88-97
[6]
Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF) [J].
Dewalle, M ;
Domingo, C ;
Rozenbaum, M ;
Ben-Chétrit, E ;
Cattan, D ;
Bernot, A ;
Dross, C ;
Dupont, M ;
Notarnicola, C ;
Levy, M ;
Rosner, I ;
Demaille, J ;
Touitou, I .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (01) :95-97
[7]
Eliakim M., 1981, RECURRENT POLYSEROSI
[8]
GERSHONIBARUCH R, 1999, HUM MUT
[9]
MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever [J].
Livneh, A ;
Langevitz, P ;
Shinar, Y ;
Zaks, N ;
Kastner, DL ;
Pras, M ;
Pras, E .
AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1999, 6 (01) :1-6
[10]
Criteria for the diagnosis of familial Mediterranean fever [J].
Livneh, A ;
Langevitz, P ;
Zemer, D ;
Zaks, N ;
Kees, S ;
Lidar, T ;
Migdal, A ;
Padeh, S ;
Pras, M .
ARTHRITIS AND RHEUMATISM, 1997, 40 (10) :1879-1885